SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-036347
Filing Date
2023-06-12
Accepted
2023-06-12 16:45:55
Documents
2
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1594
2 POA DOCUMENT poa.txt EX-24 2990
  Complete submission text file 0001209191-23-036347.txt   5961
Mailing Address 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037
Business Address
Klassen Preston (Reporting) CIK: 0001493056 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 231008758

Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations